{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T03:25:41Z","timestamp":1794885941280,"version":"4.9.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2010,11,29]],"date-time":"2010-11-29T00:00:00Z","timestamp":1290988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,11,29]],"date-time":"2010-11-29T00:00:00Z","timestamp":1290988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2011,3,31]]},"DOI":"10.1038\/onc.2010.529","type":"journal-article","created":{"date-parts":[[2010,11,30]],"date-time":"2010-11-30T13:36:56Z","timestamp":1291124216000},"page":"1518-1530","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["FGF8b oncogene mediates proliferation and invasion of Epstein\u2013Barr virus-associated nasopharyngeal carcinoma cells: implication for viral-mediated FGF8b upregulation"],"prefix":"10.1038","volume":"30","author":[{"given":"V W Y","family":"Lui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D M-S","family":"Yau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C S-F","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S C C","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A K-C","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E Y-L","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C P Y","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E K Y","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E P","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C W C","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A S-K","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P K S","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y-K","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K-W","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C M","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S K W","family":"Tsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S-W","family":"Tsao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A T C","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,11,29]]},"reference":[{"key":"BFonc2010529_CR1","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1093\/acprof:oso\/9780195149616.003.0038","volume-title":"Cancer Epidemiology and Prevention","author":"KE Anderson","year":"2006","unstructured":"Anderson KE, Mack T, Silverman DT . (2006). Cancer of the pancreas. In: Schottenfeld D, Fraumeni JF Jr (eds) Cancer Epidemiology and Prevention. Oxford University Press: New York, pp 721\u2013762."},{"key":"BFonc2010529_CR2","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1002\/pros.20376","volume":"66","author":"K Armstrong","year":"2006","unstructured":"Armstrong K, Robson CN, Leung HY . (2006). NF-kappaB activation upregulates fibroblast growth factor 8 expression in prostate cancer cells. Prostate 66: 1223\u20131234.","journal-title":"Prostate"},{"key":"BFonc2010529_CR3","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.ejso.2006.12.001","volume":"33","author":"AK Awan","year":"2007","unstructured":"Awan AK, Iftikhar SY, Morris TM, Clarke PA, Grabowska AM, Waraich N et al. (2007). Androgen receptors may act in a paracrine manner to regulate oesophageal adenocarcinoma growth. Eur J Surg Oncol 33: 561\u2013568.","journal-title":"Eur J Surg Oncol"},{"key":"BFonc2010529_CR4","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.amjoto.2003.11.005","volume":"25","author":"N Bhattacharyya","year":"2004","unstructured":"Bhattacharyya N . (2004). The impact of race on survival in nasopharyngeal carcinoma: a matched analysis. Am J Otolaryngol 25: 94\u201397.","journal-title":"Am J Otolaryngol"},{"key":"BFonc2010529_CR5","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1001\/jama.1993.03510110056031","volume":"270","author":"WJ Blot","year":"1993","unstructured":"Blot WJ, Devesa SS, Fraumeni Jr JF . (1993). Continuing climb in rates of esophageal adenocarcinoma: an update. Jama 270: 1320.","journal-title":"Jama"},{"key":"BFonc2010529_CR6","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.1074\/jbc.272.6.3733","volume":"272","author":"AG Blunt","year":"1997","unstructured":"Blunt AG, Lawshe A, Cunningham ML, Seto ML, Ornitz DM, MacArthur CA . (1997). Overlapping expression and redundant activation of mesenchymal fibroblast growth factor (FGF) receptors by alternatively spliced FGF-8 ligands. J Biol Chem 272: 3733\u20133738.","journal-title":"J Biol Chem"},{"key":"BFonc2010529_CR7","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s10549-010-0761-y","volume":"124","author":"I Castellano","year":"2010","unstructured":"Castellano I, Allia E, Accortanzo V, Vandone AM, Chiusa L, Arisio R et al. (2010). Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers. Breast Cancer Res Treat 124: 607\u2013617.","journal-title":"Breast Cancer Res Treat"},{"key":"BFonc2010529_CR8","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1093\/annonc\/mdf179","volume":"13","author":"AT Chan","year":"2002","unstructured":"Chan AT, Teo PM, Johnson PJ . (2002). Nasopharyngeal carcinoma. Ann Oncol 13: 1007\u20131015.","journal-title":"Ann Oncol"},{"key":"BFonc2010529_CR9","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/hed.20833","volume":"30","author":"J Chou","year":"2008","unstructured":"Chou J, Lin YC, Kim J, You L, Xu Z, He B et al. (2008). Nasopharyngeal carcinoma\u2014review of the molecular mechanisms of tumorigenesis. Head Neck 30: 946\u2013963.","journal-title":"Head Neck"},{"key":"BFonc2010529_CR10","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1242\/dev.121.2.439","volume":"121","author":"PH Crossley","year":"1995","unstructured":"Crossley PH, Martin GR . (1995). The mouse Fgf8 gene encodes a family of polypeptides and is expressed in regions that direct outgrowth and patterning in the developing embryo. Development 121: 439\u2013451.","journal-title":"Development"},{"key":"BFonc2010529_CR11","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/380066a0","volume":"380","author":"PH Crossley","year":"1996","unstructured":"Crossley PH, Martinez S, Martin GR . (1996). Midbrain development induced by FGF8 in the chick embryo. Nature 380: 66\u201368.","journal-title":"Nature"},{"key":"BFonc2010529_CR12","first-page":"202","volume":"15","author":"D Cui","year":"2001","unstructured":"Cui D, Zhao Y, Deng Y, Luo G, Su M, Chen X . (2001). [Clinical observation of TNF-alpha content in nasopharyngeal secretion of patients with nasopharyngeal carcinoma]. Lin Chuang Er Bi Yan Hou Ke Za Zhi 15: 202\u2013203.","journal-title":"Lin Chuang Er Bi Yan Hou Ke Za Zhi"},{"key":"BFonc2010529_CR13","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1038\/sj.onc.1202212","volume":"17","author":"D Daphna-Iken","year":"1998","unstructured":"Daphna-Iken D, Shankar DB, Lawshe A, Ornitz DM, Shackleford GM, MacArthur CA . (1998). MMTV-Fgf8 transgenic mice develop mammary and salivary gland neoplasia and ovarian stromal hyperplasia. Oncogene 17: 2711\u20132717.","journal-title":"Oncogene"},{"key":"BFonc2010529_CR14","doi-asserted-by":"publisher","first-page":"3694","DOI":"10.1074\/jbc.M209840200","volume":"278","author":"CW Dawson","year":"2003","unstructured":"Dawson CW, Tramountanis G, Eliopoulos AG, Young LS . (2003). Epstein-Barr virus latent membrane protein 1 (LMP1) activates the phosphatidylinositol 3-kinase\/Akt pathway to promote cell survival and induce actin filament remodeling. J Biol Chem 278: 3694\u20133704.","journal-title":"J Biol Chem"},{"key":"BFonc2010529_CR15","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1038\/sj.onc.1202624","volume":"18","author":"TJ Dorkin","year":"1999","unstructured":"Dorkin TJ, Robinson MC, Marsh C, Bjartell A, Neal DE, Leung HY . (1999). FGF8 over-expression in prostate cancer is associated with decreased patient survival and persists in androgen independent disease. Oncogene 18: 2755\u20132761.","journal-title":"Oncogene"},{"key":"BFonc2010529_CR16","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1006\/geno.1996.0349","volume":"35","author":"J Gemel","year":"1996","unstructured":"Gemel J, Gorry M, Ehrlich GD, MacArthur CA . (1996). Structure and sequence of human FGF8. Genomics 35: 253\u2013257.","journal-title":"Genomics"},{"key":"BFonc2010529_CR17","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1038\/sj.bjc.6600875","volume":"88","author":"VJ Gnanapragasam","year":"2003","unstructured":"Gnanapragasam VJ, Robinson MC, Marsh C, Robson CN, Hamdy FC, Leung HY . (2003). FGF8 isoform b expression in human prostate cancer. Br J Cancer 88: 1432\u20131438.","journal-title":"Br J Cancer"},{"key":"BFonc2010529_CR18","doi-asserted-by":"publisher","first-page":"5069","DOI":"10.1038\/sj.onc.1205663","volume":"21","author":"VJ Gnanapragasam","year":"2002","unstructured":"Gnanapragasam VJ, Robson CN, Neal DE, Leung HY . (2002). Regulation of FGF8 expression by the androgen receptor in human prostate cancer. Oncogene 21: 5069\u20135080.","journal-title":"Oncogene"},{"key":"BFonc2010529_CR19","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0925-4773(94)90022-1","volume":"48","author":"M Heikinheimo","year":"1994","unstructured":"Heikinheimo M, Lawshe A, Shackleford GM, Wilson DB, MacArthur CA . (1994). FGF-8 expression in the post-gastrulation mouse suggests roles in the development of the face, limbs and central nervous system. Mech Dev 48: 129\u2013138.","journal-title":"Mech Dev"},{"issue":"3","key":"BFonc2010529_CR20","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s10637-009-9356-z","volume":"29","author":"Bo Hong","year":"2009","unstructured":"Hong B, Lui VW, Hui EP, Ng MH, Cheng SH, Sung FL et al. (2009). Hypoxia-targeting by tirapazamine (TPZ) induces preferential growth inhibition of nasopharyngeal carcinoma cells with Chk1\/2 activation. Invest New Drugs (e-pub ahead of print 16 December 2009).","journal-title":"Investigational New Drugs"},{"key":"BFonc2010529_CR21","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1158\/1078-0432.CCR-04-2057","volume":"11","author":"T Ishibe","year":"2005","unstructured":"Ishibe T, Nakayama T, Okamoto T, Aoyama T, Nishijo K, Shibata KR et al. (2005). Disruption of fibroblast growth factor signal pathway inhibits the growth of synovial sarcomas: potential application of signal inhibitors to molecular target therapy. Clin Cancer Res 11: 2702\u20132712.","journal-title":"Clin Cancer Res"},{"key":"BFonc2010529_CR22","first-page":"569","volume":"93","author":"WR Kuo","year":"1994","unstructured":"Kuo WR, Yu HS, Chang KL, Juan KH, Jan YS, Yu CL . (1994). Increased production of tumor necrosis factor-alpha and release of soluble CD4 and CD8 molecules, but decreased responsiveness to phytohemagglutinin in patients with nasopharyngeal carcinoma. J Formos Med Assoc 93: 569\u2013575.","journal-title":"J Formos Med Assoc"},{"key":"BFonc2010529_CR23","first-page":"1833","volume":"12","author":"HY Leung","year":"1996","unstructured":"Leung HY, Dickson C, Robson CN, Neal DE . (1996). Over-expression of fibroblast growth factor-8 in human prostate cancer. Oncogene 12: 1833\u20131835.","journal-title":"Oncogene"},{"key":"BFonc2010529_CR24","first-page":"199","volume":"23","author":"W Liao","year":"2001","unstructured":"Liao W, Tang M, Yin L . (2001). [EBV latent membrane protein 1 induces p53 expression via NF-kappa B in nasopharyngeal carcinoma]. Zhonghua Zhong Liu Za Zhi 23: 199\u2013201.","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"BFonc2010529_CR25","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1593\/neo.05625","volume":"8","author":"AK Lo","year":"2006","unstructured":"Lo AK, Lo KW, Tsao SW, Wong HL, Hui JW, To KF et al. (2006). Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells. Neoplasia 8: 173\u2013180.","journal-title":"Neoplasia"},{"key":"BFonc2010529_CR26","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S1044579X02000883","volume":"12","author":"KW Lo","year":"2002","unstructured":"Lo KW, Huang DP . (2002). Genetic and epigenetic changes in nasopharyngeal carcinoma. Semin Cancer Biol 12: 451\u2013462.","journal-title":"Semin Cancer Biol"},{"key":"BFonc2010529_CR27","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1002\/ijc.24567","volume":"125","author":"VW Lui","year":"2009","unstructured":"Lui VW, Wong EY, Ho Y, Hong B, Wong SC, Tao Q et al. (2009a). STAT3 activation contributes directly to Epstein-Barr virus-mediated invasiveness of nasopharyngeal cancer cells in vitro. Int J Cancer 125: 1884\u20131893.","journal-title":"Int J Cancer"},{"key":"BFonc2010529_CR28","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1093\/carcin\/bgp253","volume":"30","author":"VW Lui","year":"2009","unstructured":"Lui VW, Yau DM, Wong EY, Ng YK, Lau CP, Ho Y et al. (2009b). Cucurbitacin I elicits anoikis sensitization, inhibits cellular invasion and in vivo tumor formation ability of nasopharyngeal carcinoma cells. Carcinogenesis 30: 2085\u20132094.","journal-title":"Carcinogenesis"},{"key":"BFonc2010529_CR29","first-page":"817","volume":"6","author":"CA MacArthur","year":"1995","unstructured":"MacArthur CA, Lawshe A, Shankar DB, Heikinheimo M, Shackleford GM . (1995a). FGF-8 isoforms differ in NIH3T3 cell transforming potential. Cell Growth Differ 6: 817\u2013825.","journal-title":"Cell Growth Differ"},{"key":"BFonc2010529_CR30","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1242\/dev.121.11.3603","volume":"121","author":"CA MacArthur","year":"1995","unstructured":"MacArthur CA, Lawshe A, Xu J, Santos-Ocampo S, Heikinheimo M, Chellaiah AT et al. (1995b). FGF-8 isoforms activate receptor splice forms that are expressed in mesenchymal regions of mouse development. Development 121: 3603\u20133613.","journal-title":"Development"},{"key":"BFonc2010529_CR31","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1128\/jvi.69.4.2501-2507.1995","volume":"69","author":"CA MacArthur","year":"1995","unstructured":"MacArthur CA, Shankar DB, Shackleford GM . (1995c). Fgf-8, activated by proviral insertion, cooperates with the Wnt-1 transgene in murine mammary tumorigenesis. J Virol 69: 2501\u20132507.","journal-title":"J Virol"},{"key":"BFonc2010529_CR32","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/sj.onc.1202392","volume":"18","author":"SK Marsh","year":"1999","unstructured":"Marsh SK, Bansal GS, Zammit C, Barnard R, Coope R, Roberts-Clarke D et al. (1999). Increased expression of fibroblast growth factor 8 in human breast cancer. Oncogene 18: 1053\u20131060.","journal-title":"Oncogene"},{"key":"BFonc2010529_CR33","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.cytogfr.2007.04.010","volume":"18","author":"MM Mattila","year":"2007","unstructured":"Mattila MM, Harkonen PL . (2007). Role of fibroblast growth factor 8 in growth and progression of hormonal cancer. Cytokine Growth Factor Rev 18: 257\u2013266.","journal-title":"Cytokine Growth Factor Rev"},{"key":"BFonc2010529_CR34","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0304-3835(97)00368-6","volume":"122","author":"K Ohshima","year":"1998","unstructured":"Ohshima K, Suzumiya J, Kanda M, Kato A, Kikuchi M . (1998). Integrated and episomal forms of Epstein-Barr virus (EBV) in EBV associated disease. Cancer Lett 122: 43\u201350.","journal-title":"Cancer Lett"},{"key":"BFonc2010529_CR35","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1101\/gad.1365406","volume":"20","author":"SK Olsen","year":"2006","unstructured":"Olsen SK, Li JY, Bromleigh C, Eliseenkova AV, Ibrahimi OA, Lao Z et al. (2006). Structural basis by which alternative splicing modulates the organizer activity of FGF8 in the brain. Genes Dev 20: 185\u2013198.","journal-title":"Genes Dev"},{"key":"BFonc2010529_CR36","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1093\/annonc\/mdp510","volume":"21","author":"S Park","year":"2010","unstructured":"Park S, Koo J, Park HS, Kim JH, Choi SY, Lee JH et al. (2010). Expression of androgen receptors in primary breast cancer. Ann Oncol 21: 488\u2013492. Epub 2009 Nov 3.","journal-title":"Ann Oncol"},{"key":"BFonc2010529_CR37","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1038\/sj.onc.1201652","volume":"16","author":"N Rudra-Ganguly","year":"1998","unstructured":"Rudra-Ganguly N, Zheng J, Hoang AT, Roy-Burman P . (1998). Downregulation of human FGF8 activity by antisense constructs in murine fibroblastic and human prostatic carcinoma cell systems. Oncogene 16: 1487\u20131492.","journal-title":"Oncogene"},{"key":"BFonc2010529_CR38","first-page":"4229","volume":"61","author":"JK Ruohola","year":"2001","unstructured":"Ruohola JK, Viitanen TP, Valve EM, Seppanen JA, Loponen NT, Keskitalo JJ et al. (2001). Enhanced invasion and tumor growth of fibroblast growth factor 8b-overexpressing MCF-7 human breast cancer cells. Cancer Res 61: 4229\u20134237.","journal-title":"Cancer Res"},{"key":"BFonc2010529_CR39","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1002\/ijc.22107","volume":"119","author":"W Shi","year":"2006","unstructured":"Shi W, Bastianutto C, Li A, Perez-Ordonez B, Ng R, Chow KY et al. (2006). Multiple dysregulated pathways in nasopharyngeal carcinoma revealed by gene expression profiling. Int J Cancer 119: 2467\u20132475.","journal-title":"Int J Cancer"},{"key":"BFonc2010529_CR40","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1177\/000348949110000705","volume":"100","author":"DW Skinner","year":"1991","unstructured":"Skinner DW, Van Hasselt CA, Tsao SY . (1991). Nasopharyngeal carcinoma: modes of presentation. Ann Otol Rhinol Laryngol 100: 544\u2013551.","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"BFonc2010529_CR41","first-page":"6730","volume":"60","author":"Z Song","year":"2000","unstructured":"Song Z, Powell WC, Kasahara N, van Bokhoven A, Miller GJ, Roy-Burman P . (2000). The effect of fibroblast growth factor 8, isoform b, on the biology of prostate carcinoma cells and their interaction with stromal cells. Cancer Res 60: 6730\u20136736.","journal-title":"Cancer Res"},{"key":"BFonc2010529_CR42","first-page":"5096","volume":"62","author":"Z Song","year":"2002","unstructured":"Song Z, Wu X, Powell WC, Cardiff RD, Cohen MB, Tin RT et al. (2002). Fibroblast growth factor 8 isoform B overexpression in prostate epithelium: a new mouse model for prostatic intraepithelial neoplasia. Cancer Res 62: 5096\u20135105.","journal-title":"Cancer Res"},{"key":"BFonc2010529_CR43","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1016\/S0959-8049(03)00367-8","volume":"39","author":"JP Spano","year":"2003","unstructured":"Spano JP, Busson P, Atlan D, Bourhis J, Pignon JP, Esteban C et al. (2003). Nasopharyngeal carcinomas: an update. Eur J Cancer 39: 2121\u20132135.","journal-title":"Eur J Cancer"},{"key":"BFonc2010529_CR44","first-page":"2053","volume":"58","author":"A Tanaka","year":"1998","unstructured":"Tanaka A, Furuya A, Yamasaki M, Hanai N, Kuriki K, Kamiakito T et al. (1998). High frequency of fibroblast growth factor (FGF) 8 expression in clinical prostate cancers and breast tissues, immunohistochemically demonstrated by a newly established neutralizing monoclonal antibody against FGF 8. Cancer Res 58: 2053\u20132056.","journal-title":"Cancer Res"},{"key":"BFonc2010529_CR45","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s00428-002-0687-9","volume":"441","author":"A Tanaka","year":"2002","unstructured":"Tanaka A, Kamiakito T, Takayashiki N, Sakurai S, Saito K . (2002). Fibroblast growth factor 8 expression in breast carcinoma: associations with androgen receptor and prostate-specific antigen expressions. Virchows Arch 441: 380\u2013384.","journal-title":"Virchows Arch"},{"key":"BFonc2010529_CR46","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/0014-5793(95)00324-3","volume":"363","author":"A Tanaka","year":"1995","unstructured":"Tanaka A, Miyamoto K, Matsuo H, Matsumoto K, Yoshida H . (1995). Human androgen-induced growth factor in prostrate and breast cancer cells: its molecular cloning and growth properties. FEBS Lett 363: 226\u2013230.","journal-title":"FEBS Lett"},{"key":"BFonc2010529_CR47","doi-asserted-by":"publisher","first-page":"8928","DOI":"10.1073\/pnas.89.19.8928","volume":"89","author":"A Tanaka","year":"1992","unstructured":"Tanaka A, Miyamoto K, Minamino N, Takeda M, Sato B, Matsuo H et al. (1992). Cloning and characterization of an androgen-induced growth factor essential for the androgen-dependent growth of mouse mammary carcinoma cells. Proc Natl Acad Sci USA 89: 8928\u20138932.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2010529_CR48","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1023\/A:1010753826788","volume":"46","author":"S Tanaka","year":"2001","unstructured":"Tanaka S, Ueo H, Mafune K, Mori M, Wands JR, Sugimachi K . (2001). A novel isoform of human fibroblast growth factor 8 is induced by androgens and associated with progression of esophageal carcinoma. Dig Dis Sci 46: 1016\u20131021.","journal-title":"Dig Dis Sci"},{"key":"BFonc2010529_CR49","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/cbf.1557","volume":"27","author":"V Thaver","year":"2009","unstructured":"Thaver V, Lottering ML, van Papendorp D, Joubert A . (2009). In vitro effects of 2-methoxyestradiol on cell numbers, morphology, cell cycle progression, and apoptosis induction in oesophageal carcinoma cells. Cell Biochem Funct 27: 205\u2013210.","journal-title":"Cell Biochem Funct"},{"key":"BFonc2010529_CR50","first-page":"8293","volume":"63","author":"NJ Thornburg","year":"2003","unstructured":"Thornburg NJ, Pathmanathan R, Raab-Traub N . (2003). Activation of nuclear factor-kappaB p50 homodimer\/Bcl-3 complexes in nasopharyngeal carcinoma. Cancer Res 63: 8293\u20138301.","journal-title":"Cancer Res"},{"key":"BFonc2010529_CR51","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/S1044579X02000901","volume":"12","author":"SW Tsao","year":"2002","unstructured":"Tsao SW, Tramoutanis G, Dawson CW, Lo AK, Huang DP . (2002). The significance of LMP1 expression in nasopharyngeal carcinoma. Semin Cancer Biol 12: 473\u2013487.","journal-title":"Semin Cancer Biol"},{"key":"BFonc2010529_CR52","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1242\/dev.126.1.51","volume":"126","author":"AS Tucker","year":"1999","unstructured":"Tucker AS, Yamada G, Grigoriou M, Pachnis V, Sharpe PT . (1999). Fgf-8 determines rostral-caudal polarity in the first branchial arch. Development 126: 51\u201361.","journal-title":"Development"},{"key":"BFonc2010529_CR53","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/ijc.23422","volume":"123","author":"MP Valta","year":"2008","unstructured":"Valta MP, Tuomela J, Bjartell A, Valve E, Vaananen HK, Harkonen P . (2008). FGF-8 is involved in bone metastasis of prostate cancer. Int J Cancer 123: 22\u201331.","journal-title":"Int J Cancer"},{"key":"BFonc2010529_CR54","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/labinvest.3780291","volume":"81","author":"EM Valve","year":"2001","unstructured":"Valve EM, Nevalainen MT, Nurmi MJ, Laato MK, Martikainen PM, Harkonen PL . (2001). Increased expression of FGF-8 isoforms and FGF receptors in human premalignant prostatic intraepithelial neoplasia lesions and prostate cancer. Lab Invest 81: 815\u2013826.","journal-title":"Lab Invest"},{"key":"BFonc2010529_CR55","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.canlet.2009.05.022","volume":"287","author":"JH Wong","year":"2009","unstructured":"Wong JH, Lui VW, Umezawa K, Ho Y, Wong EY, Ng MH et al. (2009). A small molecule inhibitor of NF-kappaB, dehydroxymethylepoxyquinomicin (DHMEQ), suppresses growth and invasion of nasopharyngeal carcinoma (NPC) cells. Cancer Lett 287: 23\u201332.","journal-title":"Cancer Lett"},{"key":"BFonc2010529_CR56","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/path.838","volume":"194","author":"SC Wong","year":"2001","unstructured":"Wong SC, Chan JK, Lee KC, Hsiao WL . (2001). Differential expression of p16\/p21\/p27 and cyclin D1\/D3, and their relationships to cell proliferation, apoptosis, and tumour progression in invasive ductal carcinoma of the breast. J Pathol 194: 35\u201342.","journal-title":"J Pathol"},{"key":"BFonc2010529_CR57","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/path.1035","volume":"196","author":"SC Wong","year":"2002","unstructured":"Wong SC, Lo SF, Lee KC, Yam JW, Chan JK, Wendy Hsiao WL . (2002). Expression of frizzled- related protein and Wnt-signalling molecules in invasive breast tumours. J Pathol 196: 145\u2013153.","journal-title":"J Pathol"},{"key":"BFonc2010529_CR58","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/BF02471585","volume":"19","author":"Y Yamashita","year":"1989","unstructured":"Yamashita Y, Hirai T, Mukaida H, Kawano K, Toge T, Niimoto M et al. (1989). Detection of androgen receptors in human esophageal cancer. Jpn J Surg 19: 195\u2013202.","journal-title":"Jpn J Surg"},{"key":"BFonc2010529_CR59","first-page":"185","volume":"4","author":"H Zheng","year":"2007","unstructured":"Zheng H, Li LL, Hu DS, Deng XY, Cao Y . (2007). Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma. Cell Mol Immunol 4: 185\u2013196.","journal-title":"Cell Mol Immunol"},{"key":"BFonc2010529_CR60","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1158\/0008-5472.CAN-05-3440","volume":"66","author":"C Zhong","year":"2006","unstructured":"Zhong C, Saribekyan G, Liao CP, Cohen MB, Roy-Burman P . (2006). Cooperation between FGF8b overexpression and PTEN deficiency in prostate tumorigenesis. Cancer Res 66: 2188\u20132194.","journal-title":"Cancer Res"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2010529.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2010529","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2010529.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T17:35:19Z","timestamp":1647884119000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2010529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,29]]},"references-count":60,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2011,3,31]]}},"alternative-id":["BFonc2010529"],"URL":"https:\/\/doi.org\/10.1038\/onc.2010.529","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,29]]},"assertion":[{"value":"11 March 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2010","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2010","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2010","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}